Jaguar Health Declares Special Stock Dividend for Shareholders

Jaguar Health, Inc. (NASDAQ:JAGX) has announced a special stock dividend for holders of its common stock and certain warrants. As of October 13, 2026, eligible shareholders will receive the company's Series R Convertible Preferred Stock. This stock will convert into five shares of common stock on November 2, 2026.

The special dividend aims to reward shareholders and provide protection against potential dilution. Jaguar remains focused on its global development program for oral crofelemer, targeting rare intestinal diseases such as microvillus inclusion disease and short bowel syndrome. The company anticipates filing a New Drug Application for crofelemer in mid-2027.

The payment date for the dividend is October 15, 2026. Shareholders can find more details in the Form 8-K, which will be filed with the SEC and accessible on Jaguar’s website.